A Single-center, Placebo-controlled, Double-blind Study to Evaluate the Effect of Relamorelin on Satiation, Gastric Volume, Gastric Accommodation and Distal Gastric Function in Healthy Volunteers

Trial Profile

A Single-center, Placebo-controlled, Double-blind Study to Evaluate the Effect of Relamorelin on Satiation, Gastric Volume, Gastric Accommodation and Distal Gastric Function in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Sep 2016

At a glance

  • Drugs Relamorelin (Primary)
  • Indications Constipation; Diabetic gastroparesis; Gastrointestinal disorders
  • Focus Pharmacodynamics
  • Sponsors Rhythm; Rhythm Pharmaceuticals
  • Most Recent Events

    • 24 May 2016 Results presented at the Digestive Disease Week 2016
    • 13 Oct 2015 Status changed from not yet recruiting to completed, as reported by ClinicalTrials.gov.
    • 17 Jun 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top